265 related articles for article (PubMed ID: 24598244)
1. GAD autoantibody affinity in adult patients with latent autoimmune diabetes, the study participants of a GAD65 vaccination trial.
Krause S; Landherr U; Agardh CD; Hausmann S; Link K; Hansen JM; Lynch KF; Powell M; Furmaniak J; Rees-Smith B; Bonifacio E; Ziegler AG; Lernmark A; Achenbach P
Diabetes Care; 2014 Jun; 37(6):1675-80. PubMed ID: 24598244
[TBL] [Abstract][Full Text] [Related]
2. Effect of simultaneous vaccination with H1N1 and GAD-alum on GAD
Tavira B; Cheramy M; Axelsson S; Åkerman L; Ludvigsson J; Casas R
Diabetologia; 2017 Jul; 60(7):1276-1283. PubMed ID: 28357504
[TBL] [Abstract][Full Text] [Related]
3. Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3).
Liu L; Li X; Xiang Y; Huang G; Lin J; Yang L; Zhao Y; Yang Z; Hou C; Li Y; Liu J; Zhu D; Leslie RD; Wang X; Zhou Z;
Diabetes Care; 2015 Jan; 38(1):16-21. PubMed ID: 25336751
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12.
Achenbach P; Hawa MI; Krause S; Lampasona V; Jerram ST; Williams AJK; Bonifacio E; Ziegler AG; Leslie RD;
Diabetologia; 2018 Jul; 61(7):1644-1649. PubMed ID: 29619531
[TBL] [Abstract][Full Text] [Related]
5. Persistence of glutamic acid decarboxylase antibody (GADA) is associated with clinical characteristics of latent autoimmune diabetes in adults: a prospective study with 3-year follow-up.
Huang G; Yin M; Xiang Y; Li X; Shen W; Luo S; Lin J; Xie Z; Zheng P; Zhou Z
Diabetes Metab Res Rev; 2016 Sep; 32(6):615-22. PubMed ID: 26787598
[TBL] [Abstract][Full Text] [Related]
6. GAD65 vaccination: 5 years of follow-up in a randomised dose-escalating study in adult-onset autoimmune diabetes.
Agardh CD; Lynch KF; Palmér M; Link K; Lernmark A
Diabetologia; 2009 Jul; 52(7):1363-8. PubMed ID: 19404608
[TBL] [Abstract][Full Text] [Related]
7. GAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetes.
Mayr A; Schlosser M; Grober N; Kenk H; Ziegler AG; Bonifacio E; Achenbach P
Diabetes; 2007 Jun; 56(6):1527-33. PubMed ID: 17325256
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of autoantigen-specific therapy with 2 doses of alum-formulated glutamate decarboxylase in children with multiple islet autoantibodies and risk for type 1 diabetes: A randomized clinical trial.
Elding Larsson H; Lundgren M; Jonsdottir B; Cuthbertson D; Krischer J;
Pediatr Diabetes; 2018 May; 19(3):410-419. PubMed ID: 29171140
[TBL] [Abstract][Full Text] [Related]
9. GAD autoantibody affinity in schoolchildren from the general population.
Bender C; Schlosser M; Christen U; Ziegler AG; Achenbach P
Diabetologia; 2014 Sep; 57(9):1911-8. PubMed ID: 24939430
[TBL] [Abstract][Full Text] [Related]
10. GAD autoantibody epitope pattern after GAD-alum treatment in children and adolescents with type 1 diabetes.
Skoglund C; Chéramy M; Casas R; Ludvigsson J; Hampe CS
Pediatr Diabetes; 2012 May; 13(3):244-50. PubMed ID: 21848927
[TBL] [Abstract][Full Text] [Related]
11. A 1-year pilot study of intralymphatic injections of GAD-alum in individuals with latent autoimmune diabetes in adults (LADA) with signs of high immunity: No safety concerns and resemblance to juvenile type 1 diabetes.
Hals IK; Balasuriya C; Casas R; Ludvigsson J; Björklund A; Grill V
Diabetes Obes Metab; 2023 Nov; 25(11):3400-3409. PubMed ID: 37580967
[TBL] [Abstract][Full Text] [Related]
12. GAD-alum treatment in patients with type 1 diabetes and the subsequent effect on GADA IgG subclass distribution, GAD65 enzyme activity and humoral response.
Chéramy M; Skoglund C; Johansson I; Ludvigsson J; Hampe CS; Casas R
Clin Immunol; 2010 Oct; 137(1):31-40. PubMed ID: 20580618
[TBL] [Abstract][Full Text] [Related]
13. GAD antibodies in T1D and LADA--relations to age, BMI, c-peptide, IA-2 and HLA-DRB1*03 and DRB1*04 alleles.
Weber P; Ambrosova P; Canov P; Weberova D; Kuklinek P; Meluzinova H; Matejovska-Kubesova H; Cejkova P; Bielakova K; Cerna M
Adv Gerontol; 2011; 24(2):312-8. PubMed ID: 21957594
[TBL] [Abstract][Full Text] [Related]
14. Discrepancy of glutamic acid decarboxylase 65 autoantibody results between RSR radioimmunoassay and enzyme-linked immunosorbent assay in patients with type 1 diabetes is related to autoantibody affinity.
Kawasaki E; Okada A; Uchida A; Fukuyama T; Sagara Y; Nakano Y; Tamai H; Tojikubo M; Koga N
J Diabetes Investig; 2019 Jul; 10(4):990-996. PubMed ID: 30582775
[TBL] [Abstract][Full Text] [Related]
15. Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function.
Zhu Y; Qian L; Liu Q; Zou J; Zhou Y; Yang T; Huang G; Zhou Z; Liu Y
Diabetes Metab J; 2020 Apr; 44(2):260-266. PubMed ID: 31769235
[TBL] [Abstract][Full Text] [Related]
16. GAD65 autoantibody responses in Japanese latent autoimmune diabetes in adult patients.
Maruyama T; Oak S; Shimada A; Hampe CS
Diabetes Care; 2008 Aug; 31(8):1602-7. PubMed ID: 18487477
[TBL] [Abstract][Full Text] [Related]
17. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
Lindholm E; Hallengren B; Agardh CD
Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992
[TBL] [Abstract][Full Text] [Related]
18. Therapy with GAD in diabetes.
Ludvigsson J
Diabetes Metab Res Rev; 2009 May; 25(4):307-15. PubMed ID: 19267332
[TBL] [Abstract][Full Text] [Related]
19. GAD65 autoantibody epitopes in adult patients with latent autoimmune diabetes following GAD65 vaccination.
Bekris LM; Jensen RA; Lagerquist E; Hall TR; Agardh CD; Cilio CM; Lethagen AL; Lernmark A; Robertson JA; Hampe CS
Diabet Med; 2007 May; 24(5):521-6. PubMed ID: 17367313
[TBL] [Abstract][Full Text] [Related]
20. LADA and CARDS: a prospective study of clinical outcome in established adult-onset autoimmune diabetes.
Hawa MI; Buchan AP; Ola T; Wun CC; DeMicco DA; Bao W; Betteridge DJ; Durrington PN; Fuller JH; Neil HA; Colhoun H; Leslie RD; Hitman GA
Diabetes Care; 2014 Jun; 37(6):1643-9. PubMed ID: 24722498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
